Odyssey Health (ODYY) EBITDA Margin (2014 - 2016)

Odyssey Health (ODYY) posted quarterly EBITDA Margin of 207.5% for Q3 2016, down 1394.46% quarter-over-quarter from 13.88% in Q2 2016.

Odyssey Health (ODYY) EBITDA Margin (2014 - 2016) Analysis & Trends

Odyssey Health's EBITDA Margin history runs 3 years deep, the most recent figure standing at 207.5% for Q3 2016.

In Q3 2016, EBITDA Margin changed N/A year-over-year to 207.5%; the TTM figure through Apr 2017 stood at 972.18% (down 67667.0% YoY), while the FY2016 annual figure was 196.43%, down 13582.0% from the prior year.
EBITDA Margin for Q3 2016 stood at 207.5%, down from 13.88% in the prior quarter.
The five-year high for EBITDA Margin was 13.88% in Q2 2016, with the low at 235.48% in Q2 2015.
The 3-year median for EBITDA Margin is 49.03% (2015), against an average of 106.97%.
Peak annual rise in EBITDA Margin reached 22159 bps in 2016, while the deepest fall reached 22159 bps in 2016.
Odyssey Health's EBITDA Margin stood at 28.98% in 2014, then tumbled by 712 bps to 235.48% in 2015, then rose by 12 bps to 207.5% in 2016.
Business Quant data shows ODYY's EBITDA Margin at 207.5% in Q3 2016, 13.88% in Q2 2016, and 235.48% in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	13.44%
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	25.18%
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	19.10%
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	21.65%
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	29.48%
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	24.33%
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	13.96%
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	10.30%
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	19.15%
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Download Data